BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10

• Press Releases

  Aquestive Therapeutics Broadens Patent Estate for Anaphylm™

  October 8, 2025

   · 

  9 min read
• Press Releases

  Immuron Submits IMM-529 IND to FDA

  October 8, 2025

   · 

  6 min read
• Press Releases

  Alzheimer’s Association and Edward Jones Extend Strategic Alliance Through 2030

  October 8, 2025

   · 

  4 min read
• Press Releases

  FDA Clears Celon Pharma’s Schizophrenia Drug for Phase 3 Trial

  October 8, 2025

   · 

  3 min read
• Press Releases

  ITM Presents Dosimetry Data from Phase 3 COMPETE Trial Supporting Favorable Efficacy and Safety Profile with n.c.a. 177Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors at EANM 2025 Annual Congress

  October 8, 2025

   · 

  6 min read
• Press Releases

  Newcastle Set To Benefit From New Technology to Diagnose Disease

  October 8, 2025

   · 

  4 min read
• Press Releases

  Oxford Set To Benefit From New Technology to Diagnose Disease

  October 8, 2025

   · 

  3 min read
• Press Releases

  Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multiple Sclerosis

  October 8, 2025

   · 

  21 min read
• Press Releases

  Philips announces 5,000th Zenition mobile C-arm system installation, advancing access to high-quality, efficient surgical and interventional care worldwide

  October 8, 2025

   · 

  4 min read
• Press Releases

  Confo Therapeutics Awarded VLAIO Grant for Development of Ultra-Long-Acting Antibody-Based GPCR Therapeutics in Endocrine and Metabolic Conditions

  October 8, 2025

   · 

  2 min read